Knight Therapeutics | GUD - Trade Debtors

Stock Price
6.37
Daily Change
0.07 1.11%
Monthly
10.40%
Yearly
15.61%
Q1 Forecast
6.28

Knight Therapeutics reported CAD103M in Trade Debtors for its fiscal quarter ending in September of 2024.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Akebia Therapeutics USD 61.54M 27.17M Mar/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
Avita Medical AUD 11.37M 593K Jun/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Cronos Group USD 60.4M 7.26M Sep/2025
Dianthus Therapeutics USD 5M 4.96M Sep/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Moderna USD 184M 862M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Organigram Holdings CAD 64.86M 7.31M Sep/2025
Organon & Co USD 1.48B 0 Sep/2025
Revvity USD 744.67M 64.41M Dec/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 121.49M 18.12M Mar/2025
Viatris USD 3.03B 340.3M Dec/2025
Xeris Pharmaceuticals USD 53.75M 700K Sep/2025